189 related articles for article (PubMed ID: 17920218)
1. d-alpha-Tocopheryl polyethylene glycol 1000 succinate (TPGS) modified poly(l-lactide) (PLLA) films for localized delivery of paclitaxel.
Dong Y; Zhang Z; Feng SS
Int J Pharm; 2008 Feb; 350(1-2):166-71. PubMed ID: 17920218
[TBL] [Abstract][Full Text] [Related]
2. Self-assembled nanoparticles of poly(lactide)--Vitamin E TPGS copolymers for oral chemotherapy.
Zhang Z; Feng SS
Int J Pharm; 2006 Nov; 324(2):191-8. PubMed ID: 16842944
[TBL] [Abstract][Full Text] [Related]
3. Nanoparticles of poly(lactide)/vitamin E TPGS copolymer for cancer chemotherapy: synthesis, formulation, characterization and in vitro drug release.
Zhang Z; Feng SS
Biomaterials; 2006 Jan; 27(2):262-70. PubMed ID: 16024075
[TBL] [Abstract][Full Text] [Related]
4. Folate-decorated hybrid polymeric nanoparticles for chemically and physically combined paclitaxel loading and targeted delivery.
Wang J; Liu W; Tu Q; Wang J; Song N; Zhang Y; Nie N; Wang J
Biomacromolecules; 2011 Jan; 12(1):228-34. PubMed ID: 21158381
[TBL] [Abstract][Full Text] [Related]
5. Influence of vitamin E TPGS on the properties of hydrophilic films produced by hot-melt extrusion.
Repka MA; McGinity JW
Int J Pharm; 2000 Jul; 202(1-2):63-70. PubMed ID: 10915927
[TBL] [Abstract][Full Text] [Related]
6. Paclitaxel-loaded PCL-TPGS nanoparticles: in vitro and in vivo performance compared with Abraxane®.
Bernabeu E; Helguera G; Legaspi MJ; Gonzalez L; Hocht C; Taira C; Chiappetta DA
Colloids Surf B Biointerfaces; 2014 Jan; 113():43-50. PubMed ID: 24060929
[TBL] [Abstract][Full Text] [Related]
7. Incorporation of paclitaxel solid dispersions with poloxamer188 or polyethylene glycol to tune drug release from poly(ϵ-caprolactone) films.
Shen Y; Lu F; Hou J; Shen Y; Guo S
Drug Dev Ind Pharm; 2013 Aug; 39(8):1187-96. PubMed ID: 22803692
[TBL] [Abstract][Full Text] [Related]
8. Targeted delivery of paclitaxel using folate-decorated poly(lactide)-vitamin E TPGS nanoparticles.
Pan J; Feng SS
Biomaterials; 2008 Jun; 29(17):2663-72. PubMed ID: 18396333
[TBL] [Abstract][Full Text] [Related]
9. The drug encapsulation efficiency, in vitro drug release, cellular uptake and cytotoxicity of paclitaxel-loaded poly(lactide)-tocopheryl polyethylene glycol succinate nanoparticles.
Zhang Z; Feng SS
Biomaterials; 2006 Jul; 27(21):4025-33. PubMed ID: 16564085
[TBL] [Abstract][Full Text] [Related]
10. Novel powder formulations for controlled delivery of poorly soluble anticancer drug: application and investigation of TPGS and PEG in spray-dried particulate system.
Mu L; Teo MM; Ning HZ; Tan CS; Feng SS
J Control Release; 2005 Apr; 103(3):565-75. PubMed ID: 15820404
[TBL] [Abstract][Full Text] [Related]
11. Nanoparticles of star-like copolymer mannitol-functionalized poly(lactide)-vitamin E TPGS for delivery of paclitaxel to prostate cancer cells.
Wang K; Guo L; Xiong W; Sun L; Zheng Y
J Biomater Appl; 2014 Sep; 29(3):329-40. PubMed ID: 24621530
[TBL] [Abstract][Full Text] [Related]
12. Design and evaluation of D-α tocopheryl polyethylene glycol 1000 succinate emulsified poly-ϵ-caprolactone nanoparticles for protein/peptide drug delivery.
Rayaprolu BM; Strom JG
Drug Dev Ind Pharm; 2013 Jul; 39(7):1046-52. PubMed ID: 22758209
[TBL] [Abstract][Full Text] [Related]
13. Vitamin E TPGS used as emulsifier in the solvent evaporation/extraction technique for fabrication of polymeric nanospheres for controlled release of paclitaxel (Taxol).
Mu L; Feng SS
J Control Release; 2002 Apr; 80(1-3):129-44. PubMed ID: 11943393
[TBL] [Abstract][Full Text] [Related]
14. A novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS.
Mu L; Feng SS
J Control Release; 2003 Jan; 86(1):33-48. PubMed ID: 12490371
[TBL] [Abstract][Full Text] [Related]
15. Formulation, characterization, and in vitro evaluation of quantum dots loaded in poly(lactide)-vitamin E TPGS nanoparticles for cellular and molecular imaging.
Pan J; Wang Y; Feng SS
Biotechnol Bioeng; 2008 Oct; 101(3):622-33. PubMed ID: 18727131
[TBL] [Abstract][Full Text] [Related]
16. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
Feng SS; Mei L; Anitha P; Gan CW; Zhou W
Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
[TBL] [Abstract][Full Text] [Related]
17. Comparison of poly(ε-caprolactone) chain lengths of poly(ε-caprolactone)-co-d-α-tocopheryl-poly(ethylene glycol) 1000 succinate nanoparticles for enhancement of quercetin delivery to SKBR3 breast cancer cells.
Suksiriworapong J; Phoca K; Ngamsom S; Sripha K; Moongkarndi P; Junyaprasert VB
Eur J Pharm Biopharm; 2016 Apr; 101():15-24. PubMed ID: 26802701
[TBL] [Abstract][Full Text] [Related]
18. Nanoparticles of poly(lactide)-tocopheryl polyethylene glycol succinate (PLA-TPGS) copolymers for protein drug delivery.
Lee SH; Zhang Z; Feng SS
Biomaterials; 2007 Apr; 28(11):2041-50. PubMed ID: 17250886
[TBL] [Abstract][Full Text] [Related]
19. Effect of vitamin E TPGS on immune response to nasally delivered diphtheria toxoid loaded poly(caprolactone) microparticles.
Somavarapu S; Pandit S; Gradassi G; Bandera M; Ravichandran E; Alpar OH
Int J Pharm; 2005 Jul; 298(2):344-7. PubMed ID: 15967606
[TBL] [Abstract][Full Text] [Related]
20. Solubilized delivery of paliperidone palmitate by D-alpha-tocopheryl polyethylene glycol 1000 succinate micelles for improved short-term psychotic management.
Muthu MS; Sahu AK; Sonali ; Abdulla A; Kaklotar D; Rajesh CV; Singh S; Pandey BL
Drug Deliv; 2016; 23(1):230-7. PubMed ID: 24853962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
